SCHEMBL6188501

SCHEMBL6188501

COc1ccccc1C(=O)C1CCCC1C(=O)Nn1c(C)cc2ccccc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 3/20 0.40
▸ LMNA P02545 1/20 0.40
▸ MEN1 O00255 4/20 0.39
▸ KMT2A Q03164 4/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ CASP1 P29466 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ POLB P06746 3/20 0.38
▸ KDM2B Q8NHM5 2/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ THRB P10828 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ PIN1 Q13526 1/20 0.38
▸ MAPT P10636 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6480184 0.76 MEN1 (0.57) TSHRLMNAMEN1KMT2ACYP1A2
SCHEMBL6480068 0.74 MEN1 (0.60) TSHRLMNAMEN1KMT2ACYP1A2
SCHEMBL6482423 0.73 TSHR (0.59) TSHRLMNAMEN1KMT2ACYP1A2
SCHEMBL6480930 0.73 ALDH1A1 (0.61) TSHRLMNAMEN1KMT2ACYP1A2
SCHEMBL13888766 0.64 PIN1 (0.54) LMNAMEN1KMT2APOLBKDM2B
SCHEMBL11877651 0.64 KDM2B (0.61) LMNAMEN1KMT2APOLBKDM2B
SCHEMBL4609870 0.63 PIN1 (0.59) LMNAMEN1KMT2APOLBKDM2B
SCHEMBL31465692 0.61 MAPT (0.48) TSHRMEN1KMT2ACYP1A2CYP3A4
SCHEMBL2166462 0.61 PIN1 (0.52) TSHRLMNAKMT2APOLBKDM2B
SCHEMBL31465676 0.60 KDM4E (0.46) TSHRMEN1KMT2ACYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1554271-A1 SUBSTITUTED INDOLES AND THEIR USE AS HCV INHIBITORS Rigel Pharmaceuticals, Inc. (US) 2005-07-20 — — EP disclosed
WO-2004035571-A1 SUBSTITUTED INDOLES AND THEIR USE AS HCV INHIBITORS RIGEL PHARMACEUTICALS, INC. (US) 2004-04-29 — — WO disclosed
Send feedback